Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor

Muhammad Rafehi, Enas M. Malik, Alexander Neumann, Aliaa Abdelrahman, Theodor Hanck, Vigneshwaran Namasivayam, Christa E. Müller*, Younis Baqi

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمراجعة النظراء

27 اقتباسات (Scopus)

ملخص

P2Y4 is a Gq protein-coupled receptor activated by uridine-5′-triphosphate (UTP), which is widely expressed in the body, e.g., in intestine, heart, and brain. No selective P2Y4 receptor antagonist has been described so far. Therefore, we developed and optimized P2Y4 receptor antagonists based on an anthraquinone scaffold. Potency was assessed by a fluorescence-based assay measuring inhibition of UTP-induced intracellular calcium release in 1321N1 astrocytoma cells stably transfected with the human P2Y4 receptor. The most potent compound of the present series, sodium 1-amino-4-[4-(2,4-dimethylphenylthio)phenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate (PSB-16133, 61) exhibited an IC50 value of 233 nM, selectivity versus other P2Y receptor subtypes, and is thought to act as an allosteric antagonist. A receptor homology model was built and docking studies were performed to analyze ligand-receptor interactions. Compound 64 (PSB-1699, sodium 1-amino-4-[4-(3-pyridin-3-ylmethylthio)phenylamino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate) represents the most selective P2Y4 receptor antagonist known to date. Compounds 61 and 64 are therefore anticipated to become useful tools for studying this scarcely investigated receptor.

اللغة الأصليةEnglish
الصفحات (من إلى)3020-3038
عدد الصفحات19
دوريةJournal of Medicinal Chemistry
مستوى الصوت60
رقم الإصدار7
المعرِّفات الرقمية للأشياء
حالة النشرPublished - أبريل 13 2017

ASJC Scopus subject areas

  • ???subjectarea.asjc.1300.1313???
  • ???subjectarea.asjc.3000.3002???

بصمة

أدرس بدقة موضوعات البحث “Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا